3,142
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Uveitis in Children and Adolescents

, MD, PhD, MPH, , FRANZCO, PhD, , MD, , MD, PhD & , MD

REFERENCES

  • Gupta A, Ramanan AV. Uveitis in children: diagnosis and management. Indian J Pediatr. 2016;83:71–77.
  • Wentworth BA, Freitas-Neto CA, Foster CS. Management of pediatric uveitis. F1000Prime Rep. 2014;6:41.
  • Mehta PJ, Alexander JL, Sen HN. Pediatric uveitis: new and future treatments. Curr Opin Ophthalmol. 2013;24:453–462.
  • Pilly B, Heath G, Tschuor P, et al. Overview and recent developments in the medical management of paediatric uveitis. Expert Opin Pharmacother. 2013;14:1787–1795.
  • Majumder PD, Biswas J. Pediatric uveitis: an update. Oman J Ophthalmol. 2013;6:140–150.
  • Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6:259–269.
  • Kim SJ. Diagnosis and management of noninfectious pediatric uveitis. Int Ophthalmol Clin. 2011;51:129–145.
  • Sauberan DP. Pediatric uveitis. Int Ophthalmol Clin. 2010;50:73–85.
  • Cunningham ET Jr, Suhler EB. Childhood uveitis – young patients, old problems, new perspectives. J AAPOS. 2008;12:537–538.
  • Wegscheider BL, de Smet MD. Diagnostic evaluation of children with uveitis. Int Ophthalmol Clin. 2008;48:9–19.
  • Zierhut M, Michels H, Stübiger N, et al. Uveitis in children. Int Ophthalmol Clin. 2005;45:135–156.
  • Levy-Clarke GA, Nussenblatt RB, Smith JA. Management of chronic pediatric uveitis. Curr Opin Ophthalmol. 2005;16:281–288.
  • Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. Am J Ophthalmol. 2003;135:867–878.
  • Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children. A pediatric rheumatology perspective. Am J Ophthalmol. 2003;135:879–884.
  • Smith JR. Management of uveitis in pediatric patients: special considerations. Paediatr Drugs. 2002;4:183–189.
  • Cunningham ET Jr. Uveitis in children. Ocul Immunol and Inflamm. 2000;8:251–261.
  • Miserocchi E, Fogliato G, Modorati G, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23:705–717.
  • Nagpal A, Leigh JF, Acharya NR. Epidemiology of uveitis in children. Int Ophthalmol Clin. 2008;48:1–7.
  • Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009;116:1544–1551.
  • Hettinga YM, Verhagen FH, van Genderen M, et al. Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands. Acta Ophthalmol. 2014;92:798–804.
  • Angeles-Han ST. Quality-of-life metrics in pediatric uveitis. Int Ophthalmol Clin. 2015;55:93–101.
  • Clarke SL, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14:27.
  • Hawkins MJ, Dick AD, Lee RJ, et al. Managing juvenile idiopathic arthritis-associated uveitis. Surv Ophthalmol. 2016;61:197–210.
  • Wells JM, Smith JR. Uveitis in juvenile idiopathic arthritis: recent therapeutic advances. Ophthalmic Res. 2015;54:124–127.
  • Sen ES, Dick AD, Ramanan AV. Uveitis associated with juvenile idiopathic arthritis. Nat Rev Rheumatol. 2015;11:338–348.
  • Heiligenhaus A, Minden K, Föll D, et al. Uveitis in juvenile idiopathic arthritis. Dtsch Arztebl Int. 2015;112:92–100.
  • Kalinina Ayuso V, Makhotkina N, van Tent-Hoeve M, et al. Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown. Surv Ophthalmol. 2014;59:517–531.
  • Tugal-Tutkun I, Quartier P, Bodaghi B. Disease of the year: juvenile idiopathic arthritis-associated uveitis–classification and diagnostic approach. Ocul Immunol Inflamm. 2014;22:56–63.
  • Ozdal PC, Berker N, Tugal-Tutkun I. Pars planitis: epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res. 2015;10:469–480.
  • Przeździecka-Dołyk J, Węgrzyn A, Turno-Kręcicka A, et al. Immunopathogenic background of pars planitis. Arch Immunol Ther Exp (Warsz). 2016;64:127–137.
  • Babu BM, Rathinam SR. Intermediate uveitis. Indian J Ophthalmol. 2010;58:21–27.
  • Pinheiro MA, Rocha MB, Neri BO, et al. TINU syndrome: review of the literature and case report. J Bras Nefrol. 2016;38:132–136.
  • Lei WH, Xin J, Yu XP, et al. Tubulointerstitial nephritis and uveitis syndrome in an elderly man: case report and literature review. Medicine (Baltimore). 2015;94:e2101.
  • Aguilar C, Lonngi M, de-la-Torre A. Tubulointerstitial nephritis and uveitis syndrome: Case report and review of the literature. Ocul Immunol Inflamm. 2016;24:415–421. doi: 10.3109/09273948.2015.1034374.
  • Hettinga YM, de Groot-Mijnes JD, Rothova A, et al. Infectious involvement in a tertiary center pediatric uveitis cohort. Br J Ophthalmol. 2015;99:103–107.
  • Neu N, Duchon J, Zachariah P. TORCH infections. Clin Perinatol. 2015;42:77–103.
  • Stegmann BJ, Carey JC. TORCH Infections. Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections. Curr Womens Health Rep. 2002;2:253–258.
  • Mets MB, Chhabra MS. Eye manifestations of intrauterine infections and their impact on childhood blindness. Surv Ophthalmol. 2008;53:95–111.
  • Schüler A, Coupland SE, Krause L, et al. Malignant and non-malignant uveitis-masquerade syndromes in childhood. Klin Monbl Augenheilkd. 2007;224:477–482.
  • Hettinga YM, van Genderen MM, Wieringa W, et al. Retinal dystrophy in 6 young patients who presented with intermediate uveitis. Ophthalmology. 2016; doi: http://dx.doi.org/10.1016/j.ophtha.2016.03.046. [Epub ahead of print].
  • Phatak S, Lowder C, Pavesio C. Controversies in intraocular lens implantation in pediatric uveitis. J Ophthalmic Inflamm Infect. 2016;6:12.
  • Zaborowski AG, Quinn AG, Dick AD. Cataract surgery in pediatric uveitis. J Pediatr Ophthalmol Strabismus. 2008;45:270–278.
  • Oray M, Abu Samra K, Ebrahimiadib N, et al. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15:457–465.
  • McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20:131–137.
  • Petrushkin H, Stanford M, Fortune F, Jawad, AS. Clinical review: familial Mediterranean fever-an overview of pathogenesis, symptoms, ocular manifestations, and treatment. Ocul Immunol Inflamm. 2016;24:422–430. doi: 10.3109/09273948.2015.1010012.
  • Abu Samra K, Maghsoudlou A, Roohipoor R, et al. Current treatment modalities of JIA-associated uveitis and its complications: Literature review. Ocul Immunol Inflamm. 2016;24:431–439. doi: 10.3109/09273948.2015.1115878.
  • Alim S, Özer S, Demir S, et al. Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in children with familial Mediterranean fever. Ocul Immunol Inflamm. 2016;24:372–376. doi: 10.3109/09273948.2015.1100747.
  • Kolomeyer AM, Tu Y, Miserocchi E, et al. Chronic non-infectious uveitis in patients with juvenile idiopathic arthritis. Ocul Immunol Inflamm. 2016;24:377–385. doi: 10.3109/09273948.2015.1125509.
  • Liang F, Terrada C, Ducos de Lahitte G, et al. Foveal serous retinal detachment in juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm. 2016;24:386–391. doi: 10.3109/09273948.2015.1012297.
  • Couto C, Frick MM, LaMattina K, et al. Chronic anterior uveitis in children. Ocul Immunol Inflamm. 2016;24:392–396. doi: 10.3109/09273948.2016.1167223.
  • Wiese C, Heiligenhaus A, Heinz C. Changes in inflammatory activity after glaucoma filtration surgery in children with chronic anterior uveitis. Ocul Immunol Inflamm. 2016;24:397–401. doi: 10.3109/09273948.2015.1088041.
  • Ganesh SK, Bala A, Biswas J, et al. Pattern of pediatric uveitis seen at a tertiary referral center from India. Ocul Immunol Inflamm. 2016;24:402–409. doi: 10.3109/09273948.2015.1012298.
  • Lonngi M, Aguilar MC, Ríos HA, et al. Pediatric uveitis: experience in Colombia. Ocul Immunol Inflamm. 2016;24:410–414. doi: 10.3109/09273948.2016.1160129.
  • Uzun S, Ozelce R, Gundogan FC. Letter to: “Alim S, Özer S, Demir S, et al. Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in children with familial Mediterranean fever.” Ocul Immunol Inflamm. 2016;24:476. doi: 10.3109/09273948.2016.1142575.
  • Alim S, Özer S, Demir S, et al. Response to letter from Dr. Salih Uzun, et al. Regarding “Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in children with familial Mediterranean fever.” Ocul Immunol Inflamm. 2016;24:477. doi: 10.3109/09273948.2016.1148173.
  • Mackensen F, Billing H. Tubulointerstitial nephritis and uveitis syndrome. Curr Opin Ophthalmol. 2009;20:525–531.
  • Levinson RD. Tubulointerstitial nephritis and uveitis syndrome. Int Ophthalmol Clin. 2008;48:51–59.
  • Mackensen F, Smith JR, Rosenbaum JT. Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology. 2007;114:995–999.
  • Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46:195–208.
  • Hettinga YM, Scheerlinck LM, Lilien MR, et al. The value of measuring urinary β2-microglobulin and serum creatinine for detecting tubulointerstitial nephritis and uveitis syndrome in young patients with uveitis. JAMA Ophthalmol. 2015;133:140–145.
  • Erdurmuş M, Bekdaş M, Demircioğlu F, et al. Retinal and choroidal thickness in children with familial Mediterranean fever. Ocul Immunol Inflamm. 2014;22:444–448.
  • Cassidy J, Kivlin J, Lindsley C, et al.; Section on Rheumatology; Section on Ophthalmology. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006;117:1843–1845.
  • Heiligenhaus A, Niewerth M, Ganser G, et al.; German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford). 2007;46:1015–1019.
  • Gregory AC, Kempen JH, Daniel E, et al.; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013;120:186–192.
  • Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143:840–846.
  • Sijssens KM, Rothova A, Van De Vijver DA, et al. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;144:574–579.
  • Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121:785–796.
  • Esterberg E, Acharya NR. Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect. 2012;2:21–28.
  • Cunningham ET Jr. Surveying uveitis specialists – a call for consensus. J Ophthalmic Inflamm Infect. 2012;2:61–63.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
  • Stavrou P, Murray PI. Does trabeculectomy influence the course of uveitis? Ocul Immunol Inflamm. 1999;7:103–108.
  • Ramanan AV, Dick AD, Benton D, et al.; SYCAMORE Trial Management Group. A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials. 2014;15:14.
  • Ramanan AV, Dick AD, Jones AP, et al. Adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis: The SYCAMORE Trial. Ann Rheum Dis. 2016;75:264.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.